<DOC>
	<DOC>NCT02713698</DOC>
	<brief_summary>The main purpose of this research is to develop a population pharmacokinetic and pharmacodynamic model of Propofol when used for induction and maintenance of anaesthesia, using BIS as a pharmacodynamic endpoint. A covariate analysis will be performed in order to account for variability in pharmacokinetic and pharmacodynamic parameters. The influence of age and obesity on propofol pharmacokinetic parameters will be particularly addressed.</brief_summary>
	<brief_title>Propofol Pharmacokinetics and Pharmacodynamics Modelling</brief_title>
	<detailed_description />
	<mesh_term>Propofol</mesh_term>
	<criteria>Adult patients admitted for nose or ear surgery, bariatric surgery or urgent orthopaedic surgery. Severe hepatic or renal insufficiency; Significant haemodynamic instability previous to the surgery; Allergy to eggs or propofol at the time of enrolment; Predictive criteria for difficult airway management.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Anaesthetics</keyword>
	<keyword>Intravenous</keyword>
	<keyword>Propofol</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
	<keyword>Propofol pharmacokinetic-pharmacodynamic model</keyword>
</DOC>